The campaign seeks to raise awareness about hypertension while emphasising the significance of managing blood pressure for a healthier lifestyle
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Pharmaceutical sales was flat and stood at Rs. 309 crore as compared to Rs. 308 crore in Q4 FY22
Two patents were filed during the quarter ended 31st March, 2023 and the cumulative filings till date are 3239
The company has reported total income of Rs. 11303.95 crores during the period ended March 31, 2023
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
